<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">KJIM</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Internal Medicine</journal-title><abbrev-journal-title>Korean J Intern Med</abbrev-journal-title></journal-title-group>
<issn pub-type="ppub">1226-3303</issn>
<issn pub-type="epub">2005-6648</issn>
<publisher>
<publisher-name>The Korean Association of Internal Medicine</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3904/kjim.2019.097</article-id>
<article-id pub-id-type="publisher-id">kjim-2019-097</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
<subj-group subj-group-type="heading">
<subject>Geriatrics</subject>
</subj-group></subj-group></article-categories>
<title-group>
<article-title>What are the illnesses associated with frailty in community-dwelling older adults: the Korean Frailty and Aging Cohort Study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Sunyoung</given-names></name>
<xref ref-type="aff" rid="af1-kjim-2019-097"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jung</surname><given-names>Hee-Won</given-names></name>
<xref ref-type="aff" rid="af2-kjim-2019-097"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6429-4461</contrib-id>
<name><surname>Won</surname><given-names>Chang Won</given-names></name>
<xref ref-type="corresp" rid="c1-kjim-2019-097"/>
<xref ref-type="aff" rid="af3-kjim-2019-097"><sup>3</sup></xref>
</contrib>
<aff id="af1-kjim-2019-097">
<label>1</label>Department of Family Medicine, Kyung Hee University College of Medicine, Seoul, <country>Korea</country></aff>
<aff id="af2-kjim-2019-097">
<label>2</label>Department of Internal Medicine, Seoul National University Hospital, Seoul, <country>Korea</country></aff>
<aff id="af3-kjim-2019-097">
<label>3</label>Elderly Frailty Research Center, Department of Family Medicine, Kyung Hee University College of Medicine, Seoul, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-kjim-2019-097">Correspondence to Chang Won Won, Ph.D. Elderly Frailty Research Center, Department of Family Medicine, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea Tel: +82-2-958-8700 Fax: +82-2-958-8699 E-mail: <email>chunwon62@naver.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>7</month>
<year>2020</year></pub-date>
<pub-date pub-type="epub">
<day>9</day>
<month>4</month>
<year>2020</year></pub-date>
<volume>35</volume>
<issue>4</issue>
<fpage>1004</fpage>
<lpage>1013</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>3</month>
<year>2019</year></date>
<date date-type="rev-recd">
<day>12</day>
<month>4</month>
<year>2019</year></date>
<date date-type="accepted">
<day>29</day>
<month>4</month>
<year>2019</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2020 The Korean Association of Internal Medicine</copyright-statement>
<copyright-year>2020</copyright-year>
<license>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions>
<abstract>
<sec><title>Background/Aims</title>
<p>Frailty is mainly due to an age-related decrease in the physiological reserves needed to maintain biological homeostasis, but it can also occur as a result of chronic diseases. The purpose of this study was to identify illnesses associated with frailty in Korean community-dwelling older adults.</p></sec>
<sec><title>Methods</title>
<p>This was a cross-sectional study that included 2,936 older adults aged between 70 and 84 years who had completed both interviews and physical function assessments for the Korean Frailty and Aging Cohort Study. Current illnesses diagnosed by physicians were included in the analysis. The definition of frailty was derived from the Fried frailty phenotype.</p></sec>
<sec><title>Results</title>
<p>The prevalence of hypertension, diabetes mellitus (DM), arthritis, osteoporosis, urinary incontinence, and lung disease (including asthma, chronic obstructive pulmonary disease, and chronic bronchitis) was higher in the frail group (<italic>p</italic> &lt; 0.05). After adjusting for age, sex, physical activity, alcohol, smoking, education, and presence of a spouse, the odds ratios for DM and urinary incontinence in frailty were 1.51 (95% confidence interval [CI], 1.10 to 2.01; <italic>p</italic> &#x0003d; 0.01) and 1.88 (95% CI, 1.11 to 3.18; <italic>p</italic> &#x0003d; 0.02).</p></sec>
<sec><title>Conclusions</title>
<p>In Korean community-dwelling older adults, DM and urinary incontinence were associated with frailty after adjusting for various factors. In the future, the list of comorbid diseases that are appropriate for Korean population-specific frailty assessment should be inventoried.</p></sec>
</abstract>
<kwd-group>
<kwd>Frailty</kwd>
<kwd>Illness</kwd>
<kwd>Korea</kwd>
<kwd>Aged</kwd>
<kwd>Incontinence</kwd>
</kwd-group>
</article-meta></front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Frailty is described as a loss of the ability to cope with external stressors due to diminished functional reserves and is closely related to clinical adverse outcomes including increased dependence, hospital admission, and mortality, thereby causing increased requirements for social resources that serve the aging population &#x0005b;<xref ref-type="bibr" rid="b1-kjim-2019-097">1</xref>-<xref ref-type="bibr" rid="b3-kjim-2019-097">3</xref>&#x0005d;. Frailty is measured with the Fried operationalized frailty with a phenotype model, which includes involuntary weight loss, exhaustion, slow gait, poor handgrip strength, and sedentary behavior &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>&#x0005d;. The Rockwood and Mitnitski group defined frailty using the Frailty Index, which measures cumulative deficits in the areas of physical, cognitive, psychological, and social health. Many chronic diseases are included in the Frailty Index &#x0005b;<xref ref-type="bibr" rid="b4-kjim-2019-097">4</xref>&#x0005d;.</p>
<p>Although frailty is understood to be promoted by physiological and biochemical changes due to aging together with malnutrition and a lack of physical activity, research has shown that frailty is highly associated with chronic diseases including hypertension, congestive heart failure (CHF), diabetes mellitus (DM), stroke, chronic lung disease, and cancer &#x0005b;<xref ref-type="bibr" rid="b5-kjim-2019-097">5</xref>-<xref ref-type="bibr" rid="b8-kjim-2019-097">8</xref>&#x0005d;.</p>
<p>As a simple screening method for frailty, Morley et al. &#x0005b;<xref ref-type="bibr" rid="b9-kjim-2019-097">9</xref>&#x0005d; proposed the Fatigue, Resistance, Ambulation, Illness, and Loss of Weight (FRAIL) questionnaire, with frailty being positive when five out of 11 designated illnesses are present (i.e., hypertension, DM, cancer &#x0005b;other than minor skin cancers&#x0005d;, chronic lung disease, heart attack, CHF, angina, asthma, arthritis, stroke, and kidney disease). However, only 2.1% to 2.9% of community-dwelling older adults had five or more illnesses in previous studies per this questionnaire &#x0005b;<xref ref-type="bibr" rid="b10-kjim-2019-097">10</xref>&#x0005d;. Also, asthma and chronic obstructive pulmonary disease (COPD) cannot be easily distinguished by laypersons. Indeed, studies showed that community-dwelling older adults in Korea are less aware of their illness status &#x0005b;<xref ref-type="bibr" rid="b11-kjim-2019-097">11</xref>,<xref ref-type="bibr" rid="b12-kjim-2019-097">12</xref>&#x0005d;. These observations suggest that the &#x0201c;illness items&#x0201d; used to identify high-risk frailty groups or to screen for frailty in community-dwelling older adults must be different.</p>
<p>Therefore, the aim of this study was to identify current illnesses related to frailty in community-dwelling older adults.</p>
</sec>
<sec sec-type="methods">
<title>METHODS</title>
<sec>
<title>Study population and protocol</title>
<p>This study was cross-sectional, and participants consisted of older adults aged 70 to 84 years who participated in the Korean Frailty and Aging Cohort Study (KFACS). The KFACS is a nationwide cohort study that began in 2016 for the purpose of identifying and preventing the factors that may contribute to frailty in community-dwelling older adults. The KFACS recruited 3,014 older adults for a baseline survey conducted in 2016 to 2017 at 10 centers, in a nationwide manner. Community residents with no plans to move in the next two years and with no difficulties in conversation were eligible for participation in this study &#x0005b;<xref ref-type="bibr" rid="b13-kjim-2019-097">13</xref>&#x0005d;. Uncontrolled hypertension (&gt; 180/100 mmHg), cerebrovascular accident or myocardial infarction (MI) within the past six months, and patients with active malignancy currently under therapeutic treatment were excluded. Of a total of 3,014 participants recruited during the first 2 years, 2,936 participants who completed the survey were included in the final analysis &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>&#x0005d;.</p>
</sec>
<sec>
<title>Definition of current illness</title>
<p>In the KFACS, questions about current illness are based on comorbidities according to Charlson&#x02019;s classification, which are categorized as either cardiovascular, musculoskeletal/connective tissue, pulmonary, gastrointestinal, endocrine, neurologic, genitourinary, cancer, viral, and mental/behavioral &#x0005b;<xref ref-type="bibr" rid="b14-kjim-2019-097">14</xref>&#x0005d;. Additionally, urinary incontinence and osteoporosis, relatively common illnesses in older Koreans &#x0005b;<xref ref-type="bibr" rid="b15-kjim-2019-097">15</xref>-<xref ref-type="bibr" rid="b17-kjim-2019-097">17</xref>&#x0005d;, were added to the list of diseases by researcher agreement. Current illness was confirmed through face-to-face questionnaires administered to the subjects that asked about diseases diagnosed by a doctor that were treated continuously for the previous 3 months.</p>
<p>Asthma, COPD, and chronic bronchitis were grouped collectively into the lung disease category, as laypersons, especially older adults, often cannot differentiate these diseases. Similarly, angina, CHF, and MI were grouped into the category of heart disease.</p>
</sec>
<sec>
<title>Definition of frailty</title>
<p>For a definition of frailty, we used the Fried phenotype, which comprises five components: unintended weight loss, poor grip strength, exhaustion, reduced walking speed, and low physical activity level &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>,<xref ref-type="bibr" rid="b18-kjim-2019-097">18</xref>&#x0005d;. For unintended weight loss, one point was given for unintended weight loss of 4.5 kg or more in the last year. Grip strength was measured using a hand dynamometer (Takei TKK 5401, Takei Scientific Instruments, Tokyo, Japan). In the first round of measurements, the grip strength of each hand was measured once. A second round of measurements was performed after three minutes, in which the grip strength of each hand was measured again in an alternate manner. The highest value out of the four measurements was used for the analysis. One point was given for a grip strength less than 26 kg in men or less than 18 kg in women &#x0005b;<xref ref-type="bibr" rid="b19-kjim-2019-097">19</xref>&#x0005d;. To quantify exhaustion, one point was given when the participant&#x02019;s response to either one of the following statements from the Center for Epidemiological Studies-Depression (CES-D) scale was yes for three or more days in a week: &#x0201c;I felt that everything I did was an effort&#x0201d; or &#x0201c;I could not get going&#x0201d; &#x0005b;<xref ref-type="bibr" rid="b20-kjim-2019-097">20</xref>&#x0005d;. Fried defined &#x0201c;slowness&#x0201d; in frailty phenotype as the slowest 20% of a cohort (by gender, height), but, for the sake of convenience &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>&#x0005d;, there are many studies that have suggested a single gait speed cutoff irrespective of gender and height &#x0005b;<xref ref-type="bibr" rid="b21-kjim-2019-097">21</xref>&#x0005d;. The lowest 20% cutoff values for gait speed in the six community cohorts in Japan were 1.11 m/sec for men and 1.05 m/sec for women &#x0005b;<xref ref-type="bibr" rid="b22-kjim-2019-097">22</xref>&#x0005d;. Analysis of the baseline data for the first year of the KFACS revealed that the lower 20% values were less than 0.98 m/sec for men and 0.89 m/sec for women. Furthermore, it is known that measuring with a walking start yields a result that is almost 0.1 m/sec faster than that from a standing start &#x0005b;<xref ref-type="bibr" rid="b23-kjim-2019-097">23</xref>&#x0005d;. The KFACS measured gait speed with a walking start &#x0005b;<xref ref-type="bibr" rid="b24-kjim-2019-097">24</xref>&#x0005d;. Therefore, we set the cutoff for slow gait speed to be 1 m/sec, with a 4 m/sec walking speed as the usual gait speed. For low physical activity level, one point was given for physical activity happening below 494.65 kcal per week for men and below 283.50 kcal per week for women, according to the International Physical Activity Questionnaire. These values correspond to the lowest 20% of the gender-specific total energy consumed in a general population-based survey of older adults &#x0005b;<xref ref-type="bibr" rid="b25-kjim-2019-097">25</xref>&#x0005d;. Participants with a total score of three points or more were classified as frail, those with one to two points were classified as prefrail, and those with zero points were classified as robust.</p>
</sec>
<sec>
<title>Covariates</title>
<p>Information on age, marital status, education level, drinking status, smoking status, physical activity level, number of medications, polypharmacy, and comorbidities were acquired through face-to-face interviews. Polypharmacy was defined as five or more prescribed medications per day.</p>
</sec>
<sec>
<title>Ethical approval</title>
<p>Our research plan was approved by the Institutional Review Board of Kyung Hee University, and written consent was obtained from each participant prior to commencement of the study (Approval no.: KMC IRB 2019-02-008).</p>
</sec>
<sec>
<title>Statistical methods</title>
<p>Participant characteristics are presented in the form of either mean &#x000b1; standard deviation (SD) or number (%). We performed an analysis of covariance to verify the relationships between various values, diseases, and frail status as determined by the Fried frailty phenotype. The association between frailty and disease was assessed by regression analysis. Odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated using logistic regression analysis to assess the impact of disease on frailty, after adjusting for age, sex, physical activities, smoking status, alcohol consumption, education, presence of a spouse, and polypharmacy. The SPSS version 23.0 software program (IBM Corp., Armonk, NY, USA) was used for statistical analysis, and statistical significance was determined as a <italic>p</italic> value less than 0.05.</p>
</sec>
</sec>
<sec sec-type="results">
<title>RESULTS</title>
<sec>
<title>General characteristics and illness of study participants</title>
<p>The mean age of the participants was 76 years, and 1,397 (47.6%) were male. Among the 2,936 participants, 1,324 (45.1%) were robust, 1,364 (46.5%) were prefrail, and 248 (8.4%) were frail based on the Fried frailty phenotype classification scheme. Age, sex, physical activity, body mass index, alcohol, smoking, physical activity, education, and presence of a spouse were significantly different between groups (<italic>p</italic> &lt; 0.001) (<xref rid="t1-kjim-2019-097" ref-type="table">Table 1</xref>).</p>
<p>The average number of comorbid diseases in our patient cohort was 2.4 &#x000b1; 1.7. The most prevalent illness was hypertension (58.0%), followed by arthritis (26.8%), DM (22.2%), COPD (1.1%), CHF (0.7%), angina (6.2%), MI (2.2%), stroke (4.9%), and urinary incontinence (3.8%) (<xref ref-type="supplementary-material" rid="SD1-kjim-2019-097">Supplementary Table 1</xref>).</p>
</sec>
<sec>
<title>Association between frailty and illness</title>
<p>Hypertension was observed in 53.9% of the robust group, 60.8% of the prefrail group, and 64.5% of the frail group (<italic>p</italic> &lt; 0.001). The prevalence rates of DM (<italic>p</italic> &lt; 0.001), asthma (<italic>p</italic> &#x0003d; 0.033), and arthritis (<italic>p</italic> &lt; 0.001) were also significantly higher in the frail group.</p>
<p>The prevalence of MI, CHF, angina, COPD, and chronic bronchitis trended to be higher in the frail group, although without statistical significance. When asthma, COPD, and chronic bronchitis were grouped into a lung disease group, the prevalence of lung disease was significantly higher in the frail group. However, even when angina, CHF, and MI were grouped into a single heart disease category, the prevalence of heart disease was not significantly higher in the frail group (<italic>p</italic> &#x0003d; 0.121). The prevalence rates for osteoporosis and incontinence were 21.8% and 9.7% in the frail group, respectively, which were significantly higher compared to the non-frail group (<italic>p</italic> &lt; 0.001). The prevalence of stroke in the frail group was 5.6%, which was higher than the 3.9% in the robust group, although not statistically significantly (<italic>p</italic> &#x0003d; 0.067) (<xref rid="t2-kjim-2019-097" ref-type="table">Table 2</xref>). Therefore, we considered hypertension, DM, arthritis, osteoporosis, urinary incontinence, lung disease, and stroke as illnesses associated with frailty in the community-dwelling ambulatory older population.</p>
<p>Logistic regression after adjusting for age and sex showed the ORs for DM, arthritis, and urinary incontinence for frailty were 1.53 (95% CI, 1.14 to 2.06), 1.36 (95% CI, 1.02 to 1.82), and 2.44 (95% CI, 1.48 to 4.11), respectively. After adjusting for age, sex, physical activity, alcohol, smoking, education, and presence of a spouse, the ORs for DM and urinary incontinence for frailty were 1.51 (95% CI, 1.10 to 2.01; <italic>p</italic> &#x0003d; 0.01) and 1.88 (95% CI, 1.11 to 3.18; <italic>p</italic> &#x0003d; 0.02), respectively (<xref rid="t3-kjim-2019-097" ref-type="table">Table 3</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>DISCUSSION</title>
<p>The results of this study revealed that current hypertension, DM, chronic lung disease (i.e., COPD, chronic bronchitis, emphysema, and asthma), arthritis, urinary incontinence, and osteoporosis were significantly related to frailty in Korean community-dwelling older adults.</p>
<p>Several studies have assessed the association of frailty with hypertension. Frailty is common in people with hypertension, as both conditions are associated with an unhealthy lifestyle including high BMI, large waist circumference, high smoking rate, and low physical activity rate &#x0005b;<xref ref-type="bibr" rid="b26-kjim-2019-097">26</xref>-<xref ref-type="bibr" rid="b28-kjim-2019-097">28</xref>&#x0005d;. In addition, cardiovascular diseases (CVDs) associated with hypertension can accelerate frailty, and frailty increases the risk of adverse outcomes in patients with CVD. This may be because frailty and CVD share pathobiology, particularly inflammatory biomarkers such as interleukin-6 and C-reactive protein. These factors, like immune cells and cytokines, promote atherosclerosis and damage arterial walls, affecting cellular aging and promoting frailty &#x0005b;<xref ref-type="bibr" rid="b29-kjim-2019-097">29</xref>&#x0005d;. Through this process, frailty may manifest as clinical heart disease in response to stressors such as coronary ischemia or pressure or volume overload &#x0005b;<xref ref-type="bibr" rid="b30-kjim-2019-097">30</xref>&#x0005d;, suggesting relevance of frailty in terms of development, manifestation, and progression of heart failure. Several studies indicate that patients with CHF who were frail had high risks of mortality, hospitalization, and impaired quality of life &#x0005b;<xref ref-type="bibr" rid="b31-kjim-2019-097">31</xref>-<xref ref-type="bibr" rid="b33-kjim-2019-097">33</xref>&#x0005d;. In older patients with acute coronary syndromes, frailty is associated with a significant increase in mortality &#x0005b;<xref ref-type="bibr" rid="b34-kjim-2019-097">34</xref>,<xref ref-type="bibr" rid="b35-kjim-2019-097">35</xref>&#x0005d;.</p>
<p>DM may increase the risk of both CVD and frailty &#x0005b;<xref ref-type="bibr" rid="b36-kjim-2019-097">36</xref>&#x0005d;. DM often causes functional impairments in muscles and nerves, thus leading to a deterioration in physical function. Insulin resistance or insulin depletion may be an important factor in the development of frailty in diabetes patients, since insulin is well-known as an anabolic hormone in muscle &#x0005b;<xref ref-type="bibr" rid="b37-kjim-2019-097">37</xref>&#x0005d;.</p>
<p>Frailty is an independent risk factor for the development of COPD, and COPD can lead to frailty &#x0005b;<xref ref-type="bibr" rid="b38-kjim-2019-097">38</xref>&#x0005d;. Frailty is increased in the presence of chronic respiratory disease overall, ranging from 5% to 65%. This variation is likely due to differences in the criteria used or settings studied. Physical inactivity due to breathlessness and increasing comorbidity burden in chronic respiratory disease patients increase the prevalence of frailty &#x0005b;<xref ref-type="bibr" rid="b39-kjim-2019-097">39</xref>&#x0005d;.</p>
<p>Chronic kidney disease (CKD) is known to be associated with frailty &#x0005b;<xref ref-type="bibr" rid="b5-kjim-2019-097">5</xref>-<xref ref-type="bibr" rid="b8-kjim-2019-097">8</xref>&#x0005d;. The inflammatory state related to CKD not only causes skeletal muscle resistance to insulin but is also associated with an increase in resting energy expenditure that may contribute to an imbalance in muscle protein homeostasis and, in turn, frailty syndrome &#x0005b;<xref ref-type="bibr" rid="b40-kjim-2019-097">40</xref>,<xref ref-type="bibr" rid="b41-kjim-2019-097">41</xref>&#x0005d;.</p>
<p>Similarly, stroke is known to be related to frailty. Previous studies have shown that markers of physical function were consistently associated with survival and recovery after ischemic stroke. Inflammation, kidney function, and frailty also seemed to be determinants of survival and recovery after an ischemic stroke &#x0005b;<xref ref-type="bibr" rid="b42-kjim-2019-097">42</xref>&#x0005d;.</p>
<p>In accordance with previously reported associations between arthritis, osteoporosis and disability, we found relationship between these skeletal problems and frailty spectrum in this study &#x0005b;<xref ref-type="bibr" rid="b30-kjim-2019-097">30</xref>-<xref ref-type="bibr" rid="b32-kjim-2019-097">32</xref>&#x0005d;. Similarly, functional limitation and disability are strongly associated with frailty, which affects 4% to 17% of older adults in the community &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>,<xref ref-type="bibr" rid="b43-kjim-2019-097">43</xref>&#x0005d;.</p>
<p>We found that urinary incontinence is correlated with frailty. According to the results of previous studies, the frailty factors related to urinary incontinence were falls, poor grip strength, unintentional weight loss, and slow walking speed. Slow walking may contribute to diminished mobility and lower body strength that leads to pelvic floor muscle discoordination and urinary incontinence &#x0005b;<xref ref-type="bibr" rid="b44-kjim-2019-097">44</xref>,<xref ref-type="bibr" rid="b45-kjim-2019-097">45</xref>&#x0005d;. In addition, the presence of frailty indicates a diminished physiological homeostatic capacity that is strictly correlated with a diminished capacity to use energy and leads not only to sarcopenia and cognitive decline but also increased mortality &#x0005b;<xref ref-type="bibr" rid="b46-kjim-2019-097">46</xref>-<xref ref-type="bibr" rid="b49-kjim-2019-097">49</xref>&#x0005d;.</p>
<p>In the Cardiovascular Health Study, only 9.7% of older adults with multiple morbidities were frail, while 67.7% of frail older adults had multiple morbidities &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>&#x0005d;. Non-frail older adults had an average of 1.4 chronic diseases, whereas frail older adults had an average of 2.1 chronic diseases &#x0005b;<xref ref-type="bibr" rid="b50-kjim-2019-097">50</xref>&#x0005d;. Therefore, identifying comorbid diseases might be a clinically relevant issue in approaching older adults with frailty.</p>
<p>However, community-dwelling older adults often have low awareness of their illnesses. In this study, participants indicated that their prevalence rates of COPD (1.1%), CHF (0.7%), and MI (2.2%) were lower than in previous studies &#x0005b;<xref ref-type="bibr" rid="b2-kjim-2019-097">2</xref>,<xref ref-type="bibr" rid="b5-kjim-2019-097">5</xref>,<xref ref-type="bibr" rid="b8-kjim-2019-097">8</xref>,<xref ref-type="bibr" rid="b51-kjim-2019-097">51</xref>&#x0005d;. These findings may be due to the participation of relatively healthy ambulatory people in the study or could have resulted from a low perception of these diseases in Korean older adults. Lee et al. &#x0005b;<xref ref-type="bibr" rid="b12-kjim-2019-097">12</xref>&#x0005d; reported that the awareness of cardio-cerebrovascular disease was only 8.9% among the Korean population older than 70 years of age. The prevalence of COPD is reported to be approximately 11% to 17% in Korea, and only 1.7% of the national population is reported to receive treatments for COPD &#x0005b;<xref ref-type="bibr" rid="b52-kjim-2019-097">52</xref>-<xref ref-type="bibr" rid="b54-kjim-2019-097">54</xref>&#x0005d;. In the Chronic Disease Fact Book published in 2017, awareness and treatment rates for chronic diseases (especially DM, hypertension, dyslipidemia, asthma, and COPD) were very low in Koreans &#x0005b;<xref ref-type="bibr" rid="b55-kjim-2019-097">55</xref>&#x0005d;. In addition, asthma and COPD frequently overlap, and angina, MI, and heart failure are not always easily differentiated &#x0005b;<xref ref-type="bibr" rid="b56-kjim-2019-097">56</xref>&#x0005d;.</p>
<p>Indeed, the results of the study showed a large gap between the level of awareness of illness and objective clinical data. For example, 453 (15.4%) patients in the study had an estimated glomerular filtration rate of less than 60 mL/min/1.73 m<sup>2</sup> according to the Modified Diet of Renal Disease equation, but only 46 participants (1.6%) answered that they had kidney disease. Also, while 76 participants (2.6%) reported they were diagnosed with depression, 651 participants (22.2%) were suspected to be depressive according to the short-form Geriatric Depression Scale using a cutoff value of six points or higher.</p>
<p>Chun et al. &#x0005b;<xref ref-type="bibr" rid="b57-kjim-2019-097">57</xref>&#x0005d; demonstrated that a lack of access to information, knowledge, or health care services can lead to a lack of awareness or treatment of disease, and this may be more likely to occur in older people or in rural area residents. In addition, socioeconomic status is closely related to a lower rate of health information acquisition and may affect the perception accuracy of chronic diseases &#x0005b;<xref ref-type="bibr" rid="b58-kjim-2019-097">58</xref>,<xref ref-type="bibr" rid="b59-kjim-2019-097">59</xref>&#x0005d;.</p>
<p>This study has limitations in that we could not confirm the accuracy of disease history. This may lead to a difference between actual disease findings and the results of the interviewed self-report. However, in one study conducted in Japan, there was a high degree of agreement with the actual medical history of chronic diseases &#x0005b;<xref ref-type="bibr" rid="b60-kjim-2019-097">60</xref>&#x0005d;. The average number of comorbidities was 2.4 in this community study as confirmed by the questionnaire, and the prevalence rates of hypertension and DM were 58.0% and 22.2%, respectively among the elderly in the community, also confirmed by the questionnaire. The average is not so different from the results of the &#x02018;Living profiles of older people surveys in Korea&#x02019; reported in 2014, in which the older adults had an average of 2.6 chronic diseases and prevalence rates of hypertension and DM of 56.7% and 22.6%, respectively &#x0005b;<xref ref-type="bibr" rid="b17-kjim-2019-097">17</xref>&#x0005d;. However, self-reported disease prevalence can be underestimated compared with actual disease prevalence. COPD is a representative example. Also, MI or stroke within six months, uncontrolled hypertension, and cancer under treatment were excluded from this study and, therefore, the results of CVD prevalence and cancer can be lower than those in the actual conditions.</p>
<p>Unlike many studies, heart and lung disease, and cancer were not significantly related to frailty in this study. The reason for this may be that we excluded those who had experienced a cerebrovascular accident or MI within the past six months or who had an active malignancy currently under therapeutic treatment, and this may explain why heart disease and cancer were not associated with frailty in this study. It may also result from the cross-sectional study design. In particular, many chronic diseases such as CHF, MI, and angina may cause different results in longitudinal studies because they cause functional declines and accelerate frailty. However, the purpose of this study was to investigate illnesses associated with frailty and, based on the results, we can reasonably suspect the presence of frailty in older adults with theses illnesses. Further follow-up studies on the effects of diseases on frailty will be needed in the near future.</p>
<p>Nevertheless, the strength of this study is that the sample size was comparatively large (2,936 participants) and the participants represent typical community-dwelling people aged 70 to 84 years in Korea.</p>
<p>In conclusion, hypertension, DM, chronic lung disease (COPD, chronic bronchitis, emphysema, and asthma), arthritis, urinary incontinence, and osteoporosis were significantly related to frailty in Korean community-dwelling older adults. In particular, DM, and urinary incontinence were significantly associated with frailty even after adjusting for various factors.</p>
</sec>
<sec>
<title>KEY MESSAGE</title>
<boxed-text position="float" orientation="portrait">
<p>1. Current illness was associated with a frailty phenotype in Korean community-dwelling older adults.</p>
<p>2. Diabetes mellitus and urinary incontinence were associated with frailty in Korean community-dwelling older adults.</p>
</boxed-text>
</sec>
</body>
<back>
<sec sec-type="supplementary-material"><title>Supplementary Materials</title>
<supplementary-material content-type="loca-data" id="SD1-kjim-2019-097">
<label>Supplementary Table 1.</label><caption>
<p>General characteristics of study population</p>
</caption><media mimetype="application" mime-subtype="pdf" xlink:href="kjim-2019-097-suppl.pdf"/></supplementary-material>
</sec>
<fn-group>
<fn fn-type="conflict"><p>No potential conflict of interest relevant to this article was reported.</p></fn>
</fn-group>
<ack><p>This research was supported by a grant from the Korea Health Technology R&amp;D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant no. HI15C3153).</p></ack>
<ref-list>
<title>REFERENCES</title>
<ref id="b1-kjim-2019-097">
<label>1</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>
<source>World Report on Ageing and Health</source>
<publisher-loc>Geneva (CH)</publisher-loc>
<publisher-name>World Health Organization</publisher-name>
<year>2015</year>
</element-citation></ref>
<ref id="b2-kjim-2019-097">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fried</surname><given-names>LP</given-names></name>
<name><surname>Tangen</surname><given-names>CM</given-names></name>
<name><surname>Walston</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>Frailty in older adults: evidence for a phenotype</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2001</year>
<volume>56</volume>
<fpage>M146</fpage>
<lpage>M156</lpage>
</element-citation></ref>
<ref id="b3-kjim-2019-097">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jeong</surname><given-names>HS</given-names></name>
<name><surname>Lee</surname><given-names>DW</given-names></name>
<name><surname>Park</surname><given-names>KH</given-names></name>
<etal/>
</person-group>
<article-title>Clinical factors related to frailty estimated by the Korean frailty index</article-title>
<source>J Korean Geriatr Soc</source>
<year>2013</year>
<volume>17</volume>
<fpage>71</fpage>
<lpage>78</lpage>
</element-citation></ref>
<ref id="b4-kjim-2019-097">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Rockwood</surname><given-names>K</given-names></name>
<name><surname>Mitnitski</surname><given-names>A</given-names></name>
</person-group>
<article-title>Frailty in relation to the accumulation of deficits</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2007</year>
<volume>62</volume>
<fpage>722</fpage>
<lpage>727</lpage>
</element-citation></ref>
<ref id="b5-kjim-2019-097">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weiss</surname><given-names>CO</given-names></name>
</person-group>
<article-title>Frailty and chronic diseases in older adults</article-title>
<source>Clin Geriatr Med</source>
<year>2011</year>
<volume>27</volume>
<fpage>39</fpage>
<lpage>52</lpage>
</element-citation></ref>
<ref id="b6-kjim-2019-097">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chaves</surname><given-names>PH</given-names></name>
<name><surname>Semba</surname><given-names>RD</given-names></name>
<name><surname>Leng</surname><given-names>SX</given-names></name>
<etal/>
</person-group>
<article-title>Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women&#x02019;s Health and Aging Studies I and II</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2005</year>
<volume>60</volume>
<fpage>729</fpage>
<lpage>735</lpage>
</element-citation></ref>
<ref id="b7-kjim-2019-097">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Carneiro</surname><given-names>JA</given-names></name>
<name><surname>Ramos</surname><given-names>GC</given-names></name>
<name><surname>Barbosa</surname><given-names>AT</given-names></name>
<name><surname>Mendonca</surname><given-names>JM</given-names></name>
<name><surname>Costa</surname><given-names>FM</given-names></name>
<name><surname>Caldeira</surname><given-names>AP</given-names></name>
</person-group>
<article-title>Prevalence and factors associated with frailty in non-institutionalized older adults</article-title>
<source>Rev Bras Enferm</source>
<year>2016</year>
<volume>69</volume>
<fpage>435</fpage>
<lpage>442</lpage>
</element-citation></ref>
<ref id="b8-kjim-2019-097">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Thorpe</surname><given-names>RJ</given-names><suffix>Jr</suffix></name>
<name><surname>Weiss</surname><given-names>C</given-names></name>
<name><surname>Xue</surname><given-names>QL</given-names></name>
<name><surname>Fried</surname><given-names>L</given-names></name>
</person-group>
<article-title>Transitions among disability levels or death in African American and white older women</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2009</year>
<volume>64</volume>
<fpage>670</fpage>
<lpage>674</lpage>
</element-citation></ref>
<ref id="b9-kjim-2019-097">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Morley</surname><given-names>JE</given-names></name>
<name><surname>Malmstrom</surname><given-names>TK</given-names></name>
<name><surname>Miller</surname><given-names>DK</given-names></name>
</person-group>
<article-title>A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans</article-title>
<source>J Nutr Health Aging</source>
<year>2012</year>
<volume>16</volume>
<fpage>601</fpage>
<lpage>608</lpage>
</element-citation></ref>
<ref id="b10-kjim-2019-097">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>HW</given-names></name>
<name><surname>Yoo</surname><given-names>HJ</given-names></name>
<name><surname>Park</surname><given-names>SY</given-names></name>
<etal/>
</person-group>
<article-title>The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderly</article-title>
<source>Korean J Intern Med</source>
<year>2016</year>
<volume>31</volume>
<fpage>594</fpage>
<lpage>600</lpage>
</element-citation></ref>
<ref id="b11-kjim-2019-097">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Leem</surname><given-names>AY</given-names></name>
<name><surname>Park</surname><given-names>B</given-names></name>
<name><surname>Kim</surname><given-names>YS</given-names></name>
<name><surname>Jung</surname><given-names>JY</given-names></name>
<name><surname>Won</surname><given-names>S</given-names></name>
</person-group>
<article-title>Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort</article-title>
<source>Int J Chron Obstruct Pulmon Dis</source>
<year>2018</year>
<volume>13</volume>
<fpage>509</fpage>
<lpage>517</lpage>
</element-citation></ref>
<ref id="b12-kjim-2019-097">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>YH</given-names></name>
<name><surname>Noh</surname><given-names>SE</given-names></name>
</person-group>
<article-title>Factors related to awareness of cardio-cerebrovascular disease among Korean adults: the 2013 community health survey</article-title>
<source>Korean J Health Promot</source>
<year>2017</year>
<volume>17</volume>
<fpage>99</fpage>
<lpage>108</lpage>
</element-citation></ref>
<ref id="b13-kjim-2019-097">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Won</surname><given-names>CW</given-names></name>
<name><surname>Lee</surname><given-names>Y</given-names></name>
<name><surname>Choi</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>Starting construction of frailty cohort for elderly and intervention study</article-title>
<source>Ann Geriatr Med Res</source>
<year>2016</year>
<volume>20</volume>
<fpage>114</fpage>
<lpage>117</lpage>
</element-citation></ref>
<ref id="b14-kjim-2019-097">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Charlson</surname><given-names>ME</given-names></name>
<name><surname>Pompei</surname><given-names>P</given-names></name>
<name><surname>Ales</surname><given-names>KL</given-names></name>
<name><surname>MacKenzie</surname><given-names>CR</given-names></name>
</person-group>
<article-title>A new method of classifying prognostic comorbidity in longitudinal studies: development and validation</article-title>
<source>J Chronic Dis</source>
<year>1987</year>
<volume>40</volume>
<fpage>373</fpage>
<lpage>383</lpage>
</element-citation></ref>
<ref id="b15-kjim-2019-097">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>KS</given-names></name>
<name><surname>Sung</surname><given-names>HH</given-names></name>
<name><surname>Na</surname><given-names>S</given-names></name>
<name><surname>Choo</surname><given-names>MS</given-names></name>
</person-group>
<article-title>Prevalence of urinary incontinence in Korean women: results of a National Health Interview Survey</article-title>
<source>World J Urol</source>
<year>2008</year>
<volume>26</volume>
<fpage>179</fpage>
<lpage>185</lpage>
</element-citation></ref>
<ref id="b16-kjim-2019-097">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>Y</given-names></name>
<name><surname>Kim</surname><given-names>JH</given-names></name>
<name><surname>Cho</surname><given-names>DS</given-names></name>
</person-group>
<article-title>Gender difference in osteoporosis prevalence, awareness and treatment: based on the Korea national health and nutrition examination survey 2008-2011</article-title>
<source>J Korean Acad Nurs</source>
<year>2015</year>
<volume>45</volume>
<fpage>293</fpage>
<lpage>305</lpage>
</element-citation></ref>
<ref id="b17-kjim-2019-097">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Oh</surname><given-names>YH</given-names></name>
</person-group>
<article-title>The health status of older Koreans and policy considerations</article-title>
<source>Health and Welfare Forum</source>
<year>2015</year>
<volume>223</volume>
<fpage>29</fpage>
<lpage>39</lpage>
</element-citation></ref>
<ref id="b18-kjim-2019-097">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>KJ</given-names></name>
<name><surname>Shin</surname><given-names>J</given-names></name>
<name><surname>Choi</surname><given-names>J</given-names></name>
<name><surname>Won</surname><given-names>CW</given-names></name>
</person-group>
<article-title>Discrepancies in the prevalence of known frailty scales: Korean Frailty and Aging Cohort Study</article-title>
<source>Ann Geriatr Med Res</source>
<year>2018</year>
<volume>22</volume>
<fpage>137</fpage>
<lpage>144</lpage>
</element-citation></ref>
<ref id="b19-kjim-2019-097">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>LK</given-names></name>
<name><surname>Liu</surname><given-names>LK</given-names></name>
<name><surname>Woo</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia</article-title>
<source>J Am Med Dir Assoc</source>
<year>2014</year>
<volume>15</volume>
<fpage>95</fpage>
<lpage>101</lpage>
</element-citation></ref>
<ref id="b20-kjim-2019-097">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Orme</surname><given-names>JG</given-names></name>
<name><surname>Reis</surname><given-names>J</given-names></name>
<name><surname>Herz</surname><given-names>EJ</given-names></name>
</person-group>
<article-title>Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) scale</article-title>
<source>J Clin Psychol</source>
<year>1986</year>
<volume>42</volume>
<fpage>28</fpage>
<lpage>33</lpage>
</element-citation></ref>
<ref id="b21-kjim-2019-097">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Studenski</surname><given-names>S</given-names></name>
</person-group>
<article-title>Bradypedia: is gait speed ready for clinical use?</article-title>
<source>J Nutr Health Aging</source>
<year>2009</year>
<volume>13</volume>
<fpage>878</fpage>
<lpage>880</lpage>
</element-citation></ref>
<ref id="b22-kjim-2019-097">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Seino</surname><given-names>S</given-names></name>
<name><surname>Shinkai</surname><given-names>S</given-names></name>
<name><surname>Fujiwara</surname><given-names>Y</given-names></name>
<etal/>
</person-group>
<article-title>Reference values and age and sex differences in physical performance measures for community-dwelling older Japanese: a pooled analysis of six cohort studies</article-title>
<source>PLoS One</source>
<year>2014</year>
<volume>9</volume>
<elocation-id>e99487</elocation-id>
</element-citation></ref>
<ref id="b23-kjim-2019-097">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sustakoski</surname><given-names>A</given-names></name>
<name><surname>Perera</surname><given-names>S</given-names></name>
<name><surname>VanSwearingen</surname><given-names>JM</given-names></name>
<name><surname>Studenski</surname><given-names>SA</given-names></name>
<name><surname>Brach</surname><given-names>JS</given-names></name>
</person-group>
<article-title>The impact of testing protocol on recorded gait speed</article-title>
<source>Gait Posture</source>
<year>2015</year>
<volume>41</volume>
<fpage>329</fpage>
<lpage>331</lpage>
</element-citation></ref>
<ref id="b24-kjim-2019-097">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>HW</given-names></name>
<name><surname>Roh</surname><given-names>HC</given-names></name>
<name><surname>Kim</surname><given-names>SW</given-names></name>
<name><surname>Kim</surname><given-names>S</given-names></name>
<name><surname>Kim</surname><given-names>M</given-names></name>
<name><surname>Won</surname><given-names>CW</given-names></name>
</person-group>
<article-title>Cross-comparisons of gait speeds by automatic sensors and a stopwatch to provide converting formula between measuring modalities</article-title>
<source>Ann Geriatr Med Res</source>
<year>2019</year>
<volume>23</volume>
<fpage>71</fpage>
<lpage>76</lpage>
</element-citation></ref>
<ref id="b25-kjim-2019-097">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Son</surname><given-names>JH</given-names></name>
<name><surname>Kim</surname><given-names>SY</given-names></name>
<name><surname>Won</surname><given-names>CW</given-names></name>
<name><surname>Choi</surname><given-names>HR</given-names></name>
<name><surname>Kim</surname><given-names>BS</given-names></name>
<name><surname>Park</surname><given-names>MS</given-names></name>
</person-group>
<article-title>Physical frailty predicts medical expenses in community-dwelling, elderly patients: three-year prospective findings from living profiles of older people surveys in Korea</article-title>
<source>Eur Geriatr Med</source>
<year>2015</year>
<volume>6</volume>
<fpage>412</fpage>
<lpage>416</lpage>
</element-citation></ref>
<ref id="b26-kjim-2019-097">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>MG</given-names></name>
<name><surname>Kim</surname><given-names>SW</given-names></name>
<name><surname>Yoon</surname><given-names>SJ</given-names></name>
<name><surname>Choi</surname><given-names>JY</given-names></name>
<name><surname>Kim</surname><given-names>KI</given-names></name>
<name><surname>Kim</surname><given-names>CH</given-names></name>
</person-group>
<article-title>Association between frailty and hypertension prevalence, treatment, and control in the elderly Korean population</article-title>
<source>Sci Rep</source>
<year>2017</year>
<volume>7</volume>
<fpage>7542</fpage>
</element-citation></ref>
<ref id="b27-kjim-2019-097">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bastos-Barbosa</surname><given-names>RG</given-names></name>
<name><surname>Ferriolli</surname><given-names>E</given-names></name>
<name><surname>Coelho</surname><given-names>EB</given-names></name>
<name><surname>Moriguti</surname><given-names>JC</given-names></name>
<name><surname>Nobre</surname><given-names>F</given-names></name>
<name><surname>Lima</surname><given-names>NK</given-names></name>
</person-group>
<article-title>Association of frailty syndrome in the elderly with higher blood pressure and other cardiovascular risk factors</article-title>
<source>Am J Hypertens</source>
<year>2012</year>
<volume>25</volume>
<fpage>1156</fpage>
<lpage>1161</lpage>
</element-citation></ref>
<ref id="b28-kjim-2019-097">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vetrano</surname><given-names>DL</given-names></name>
<name><surname>Palmer</surname><given-names>KM</given-names></name>
<name><surname>Galluzzo</surname><given-names>L</given-names></name>
<etal/>
</person-group>
<article-title>Hypertension and frailty: a systematic review and meta-analysis</article-title>
<source>BMJ Open</source>
<year>2018</year>
<volume>8</volume>
<elocation-id>e024406</elocation-id>
</element-citation></ref>
<ref id="b29-kjim-2019-097">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weiss</surname><given-names>CO</given-names></name>
<name><surname>Hoenig</surname><given-names>HH</given-names></name>
<name><surname>Varadhan</surname><given-names>R</given-names></name>
<name><surname>Simonsick</surname><given-names>EM</given-names></name>
<name><surname>Fried</surname><given-names>LP</given-names></name>
</person-group>
<article-title>Relationships of cardiac, pulmonary, and muscle reserves and frailty to exercise capacity in older women</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2010</year>
<volume>65</volume>
<fpage>287</fpage>
<lpage>294</lpage>
</element-citation></ref>
<ref id="b30-kjim-2019-097">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Afilalo</surname><given-names>J</given-names></name>
<name><surname>Alexander</surname><given-names>KP</given-names></name>
<name><surname>Mack</surname><given-names>MJ</given-names></name>
<etal/>
</person-group>
<article-title>Frailty assessment in the cardiovascular care of older adults</article-title>
<source>J Am Coll Cardiol</source>
<year>2014</year>
<volume>63</volume>
<fpage>747</fpage>
<lpage>762</lpage>
</element-citation></ref>
<ref id="b31-kjim-2019-097">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Khan</surname><given-names>H</given-names></name>
<name><surname>Kalogeropoulos</surname><given-names>AP</given-names></name>
<name><surname>Georgiopoulou</surname><given-names>VV</given-names></name>
<etal/>
</person-group>
<article-title>Frailty and risk for heart failure in older adults: the health, aging, and body composition study</article-title>
<source>Am Heart J</source>
<year>2013</year>
<volume>166</volume>
<fpage>887</fpage>
<lpage>894</lpage>
</element-citation></ref>
<ref id="b32-kjim-2019-097">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chaudhry</surname><given-names>SI</given-names></name>
<name><surname>McAvay</surname><given-names>G</given-names></name>
<name><surname>Chen</surname><given-names>S</given-names></name>
<etal/>
</person-group>
<article-title>Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study</article-title>
<source>J Am Coll Cardiol</source>
<year>2013</year>
<volume>61</volume>
<fpage>635</fpage>
<lpage>642</lpage>
</element-citation></ref>
<ref id="b33-kjim-2019-097">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Cacciatore</surname><given-names>F</given-names></name>
<name><surname>Abete</surname><given-names>P</given-names></name>
<name><surname>Mazzella</surname><given-names>F</given-names></name>
<etal/>
</person-group>
<article-title>Frailty predicts long-term mortality in elderly subjects with chronic heart failure</article-title>
<source>Eur J Clin Invest</source>
<year>2005</year>
<volume>35</volume>
<fpage>723</fpage>
<lpage>730</lpage>
</element-citation></ref>
<ref id="b34-kjim-2019-097">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>M</given-names></name>
<name><surname>Rihal</surname><given-names>CS</given-names></name>
<name><surname>Lennon</surname><given-names>RJ</given-names></name>
<name><surname>Spertus</surname><given-names>JA</given-names></name>
<name><surname>Nair</surname><given-names>KS</given-names></name>
<name><surname>Roger</surname><given-names>VL</given-names></name>
</person-group>
<article-title>Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization</article-title>
<source>Circ Cardiovasc Qual Outcomes</source>
<year>2011</year>
<volume>4</volume>
<fpage>496</fpage>
<lpage>502</lpage>
</element-citation></ref>
<ref id="b35-kjim-2019-097">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Gharacholou</surname><given-names>SM</given-names></name>
<name><surname>Roger</surname><given-names>VL</given-names></name>
<name><surname>Lennon</surname><given-names>RJ</given-names></name>
<etal/>
</person-group>
<article-title>Comparison of frail patients versus nonfrail patients &#x02265;65 years of age undergoing percutaneous coronary intervention</article-title>
<source>Am J Cardiol</source>
<year>2012</year>
<volume>109</volume>
<fpage>1569</fpage>
<lpage>1575</lpage>
</element-citation></ref>
<ref id="b36-kjim-2019-097">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Stewart</surname><given-names>R</given-names></name>
</person-group>
<article-title>Cardiovascular disease and frailty: what are the mechanistic links?</article-title>
<source>Clin Chem</source>
<year>2019</year>
<volume>65</volume>
<fpage>80</fpage>
<lpage>86</lpage>
</element-citation></ref>
<ref id="b37-kjim-2019-097">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yanase</surname><given-names>T</given-names></name>
<name><surname>Yanagita</surname><given-names>I</given-names></name>
<name><surname>Muta</surname><given-names>K</given-names></name>
<name><surname>Nawata</surname><given-names>H</given-names></name>
</person-group>
<article-title>Frailty in elderly diabetes patients</article-title>
<source>Endocr J</source>
<year>2018</year>
<volume>65</volume>
<fpage>1</fpage>
<lpage>11</lpage>
</element-citation></ref>
<ref id="b38-kjim-2019-097">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guan</surname><given-names>C</given-names></name>
<name><surname>Niu</surname><given-names>H</given-names></name>
</person-group>
<article-title>Frailty assessment in older adults with chronic obstructive respiratory diseases</article-title>
<source>Clin Interv Aging</source>
<year>2018</year>
<volume>13</volume>
<fpage>1513</fpage>
<lpage>1524</lpage>
</element-citation></ref>
<ref id="b39-kjim-2019-097">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bone</surname><given-names>AE</given-names></name>
<name><surname>Hepgul</surname><given-names>N</given-names></name>
<name><surname>Kon</surname><given-names>S</given-names></name>
<name><surname>Maddocks</surname><given-names>M</given-names></name>
</person-group>
<article-title>Sarcopenia and frailty in chronic respiratory disease</article-title>
<source>Chron Respir Dis</source>
<year>2017</year>
<volume>14</volume>
<fpage>85</fpage>
<lpage>99</lpage>
</element-citation></ref>
<ref id="b40-kjim-2019-097">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Carrero</surname><given-names>JJ</given-names></name>
<name><surname>Stenvinkel</surname><given-names>P</given-names></name>
<name><surname>Cuppari</surname><given-names>L</given-names></name>
<etal/>
</person-group>
<article-title>Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM)</article-title>
<source>J Ren Nutr</source>
<year>2013</year>
<volume>23</volume>
<fpage>77</fpage>
<lpage>90</lpage>
</element-citation></ref>
<ref id="b41-kjim-2019-097">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JC</given-names></name>
<name><surname>Kalantar-Zadeh</surname><given-names>K</given-names></name>
<name><surname>Kopple</surname><given-names>JD</given-names></name>
</person-group>
<article-title>Frailty and protein-energy wasting in elderly patients with end stage kidney disease</article-title>
<source>J Am Soc Nephrol</source>
<year>2013</year>
<volume>24</volume>
<fpage>337</fpage>
<lpage>351</lpage>
</element-citation></ref>
<ref id="b42-kjim-2019-097">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Winovich</surname><given-names>DT</given-names></name>
<name><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></name>
<name><surname>Arnold</surname><given-names>AM</given-names></name>
<etal/>
</person-group>
<article-title>Factors associated with ischemic stroke survival and recovery in older adults</article-title>
<source>Stroke</source>
<year>2017</year>
<volume>48</volume>
<fpage>1818</fpage>
<lpage>1826</lpage>
</element-citation></ref>
<ref id="b43-kjim-2019-097">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Misra</surname><given-names>D</given-names></name>
<name><surname>Felson</surname><given-names>DT</given-names></name>
<name><surname>Silliman</surname><given-names>RA</given-names></name>
<etal/>
</person-group>
<article-title>Knee osteoarthritis and frailty: findings from the Multicenter Osteoarthritis Study and Osteoarthritis Initiative</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2015</year>
<volume>70</volume>
<fpage>339</fpage>
<lpage>344</lpage>
</element-citation></ref>
<ref id="b44-kjim-2019-097">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Nygaard</surname><given-names>IE</given-names></name>
<name><surname>Shaw</surname><given-names>JM</given-names></name>
</person-group>
<article-title>Physical activity and the pelvic floor</article-title>
<source>Am J Obstet Gynecol</source>
<year>2016</year>
<volume>214</volume>
<fpage>164</fpage>
<lpage>171</lpage>
</element-citation></ref>
<ref id="b45-kjim-2019-097">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>CJ</given-names></name>
<name><surname>Hung</surname><given-names>CH</given-names></name>
<name><surname>Tang</surname><given-names>TC</given-names></name>
<etal/>
</person-group>
<article-title>Urinary incontinence and its association with frailty among men aged 80 years or older in Taiwan: a cross-sectional study</article-title>
<source>Rejuvenation Res</source>
<year>2017</year>
<volume>20</volume>
<fpage>111</fpage>
<lpage>117</lpage>
</element-citation></ref>
<ref id="b46-kjim-2019-097">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Berardelli</surname><given-names>M</given-names></name>
<name><surname>De Rango</surname><given-names>F</given-names></name>
<name><surname>Morelli</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Urinary incontinence in the elderly and in the oldest old: correlation with frailty and mortality</article-title>
<source>Rejuvenation Res</source>
<year>2013</year>
<volume>16</volume>
<fpage>206</fpage>
<lpage>211</lpage>
</element-citation></ref>
<ref id="b47-kjim-2019-097">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>J</given-names></name>
<name><surname>Kim</surname><given-names>C</given-names></name>
</person-group>
<article-title>Association between urinary incontinence and physical frailty in Korea</article-title>
<source>Australas J Ageing</source>
<year>2018</year>
<volume>37</volume>
<fpage>E104</fpage>
<lpage>E109</lpage>
</element-citation></ref>
<ref id="b48-kjim-2019-097">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schumpf</surname><given-names>LF</given-names></name>
<name><surname>Theill</surname><given-names>N</given-names></name>
<name><surname>Scheiner</surname><given-names>DA</given-names></name>
<name><surname>Fink</surname><given-names>D</given-names></name>
<name><surname>Riese</surname><given-names>F</given-names></name>
<name><surname>Betschart</surname><given-names>C</given-names></name>
</person-group>
<article-title>Urinary incontinence and its association with functional physical and cognitive health among female nursing home residents in Switzerland</article-title>
<source>BMC Geriatr</source>
<year>2017</year>
<volume>17</volume>
<fpage>17</fpage>
</element-citation></ref>
<ref id="b49-kjim-2019-097">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>John</surname><given-names>G</given-names></name>
<name><surname>Bardini</surname><given-names>C</given-names></name>
<name><surname>Combescure</surname><given-names>C</given-names></name>
<name><surname>Dallenbach</surname><given-names>P</given-names></name>
</person-group>
<article-title>Urinary incontinence as a predictor of death: a systematic review and meta-analysis</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<elocation-id>e0158992</elocation-id>
</element-citation></ref>
<ref id="b50-kjim-2019-097">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hirsch</surname><given-names>C</given-names></name>
<name><surname>Anderson</surname><given-names>ML</given-names></name>
<name><surname>Newman</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>The association of race with frailty: the cardiovascular health study</article-title>
<source>Ann Epidemiol</source>
<year>2006</year>
<volume>16</volume>
<fpage>545</fpage>
<lpage>553</lpage>
</element-citation></ref>
<ref id="b51-kjim-2019-097">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bandeen-Roche</surname><given-names>K</given-names></name>
<name><surname>Xue</surname><given-names>QL</given-names></name>
<name><surname>Ferrucci</surname><given-names>L</given-names></name>
<etal/>
</person-group>
<article-title>Phenotype of frailty: characterization in the women&#x02019;s health and aging studies</article-title>
<source>J Gerontol A Biol Sci Med Sci</source>
<year>2006</year>
<volume>61</volume>
<fpage>262</fpage>
<lpage>266</lpage>
</element-citation></ref>
<ref id="b52-kjim-2019-097">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>An</surname><given-names>TJ</given-names></name>
<name><surname>Yoon</surname><given-names>HK</given-names></name>
</person-group>
<article-title>Prevalence and socioeconomic burden of chronic obstructive pulmonary disease</article-title>
<source>J Korean Med Assoc</source>
<year>2018</year>
<volume>61</volume>
<fpage>533</fpage>
<lpage>538</lpage>
</element-citation></ref>
<ref id="b53-kjim-2019-097">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Yoo</surname><given-names>KH</given-names></name>
<name><surname>Kim</surname><given-names>YS</given-names></name>
<name><surname>Sheen</surname><given-names>SS</given-names></name>
<etal/>
</person-group>
<article-title>Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008</article-title>
<source>Respirology</source>
<year>2011</year>
<volume>16</volume>
<fpage>659</fpage>
<lpage>665</lpage>
</element-citation></ref>
<ref id="b54-kjim-2019-097">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>YI</given-names></name>
<name><surname>Park</surname><given-names>YB</given-names></name>
<name><surname>Yoo</surname><given-names>KH</given-names></name>
</person-group>
<article-title>Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea</article-title>
<source>Tuberc Respir Dis (Seoul)</source>
<year>2017</year>
<volume>80</volume>
<fpage>226</fpage>
<lpage>229</lpage>
</element-citation></ref>
<ref id="b55-kjim-2019-097">
<label>55</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Jung</surname><given-names>EK</given-names></name>
</person-group>
<source>2017 Chronic Disease Status and Issues, Chronic Disease Fact Book</source>
<publisher-loc>Osong (KR)</publisher-loc>
<publisher-name>Korea Center for Disease Control and Prevention</publisher-name>
<year>2017</year>
<fpage>1</fpage>
<lpage>92</lpage>
</element-citation></ref>
<ref id="b56-kjim-2019-097">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SR</given-names></name>
<name><surname>Rhee</surname><given-names>YK</given-names></name>
</person-group>
<article-title>Overlap between asthma and COPD: where the two diseases converge</article-title>
<source>Allergy Asthma Immunol Res</source>
<year>2010</year>
<volume>2</volume>
<fpage>209</fpage>
<lpage>214</lpage>
</element-citation></ref>
<ref id="b57-kjim-2019-097">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chun</surname><given-names>H</given-names></name>
<name><surname>Kim</surname><given-names>IH</given-names></name>
<name><surname>Min</surname><given-names>KD</given-names></name>
</person-group>
<article-title>Accuracy of self-reported hypertension, diabetes, and hypercholesterolemia: analysis of a representative sample of Korean older adults</article-title>
<source>Osong Public Health Res Perspect</source>
<year>2016</year>
<volume>7</volume>
<fpage>108</fpage>
<lpage>115</lpage>
</element-citation></ref>
<ref id="b58-kjim-2019-097">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lopez</surname><given-names>AD</given-names></name>
<name><surname>Mathers</surname><given-names>CD</given-names></name>
<name><surname>Ezzati</surname><given-names>M</given-names></name>
<name><surname>Jamison</surname><given-names>DT</given-names></name>
<name><surname>Murray</surname><given-names>CJ</given-names></name>
</person-group>
<article-title>Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data</article-title>
<source>Lancet</source>
<year>2006</year>
<volume>367</volume>
<fpage>1747</fpage>
<lpage>1757</lpage>
</element-citation></ref>
<ref id="b59-kjim-2019-097">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>Y</given-names></name>
<name><surname>Ma</surname><given-names>W</given-names></name>
<name><surname>Yi</surname><given-names>X</given-names></name>
<etal/>
</person-group>
<article-title>Chronic diseases knowledge and related factors among the elderly I Jinan, China</article-title>
<source>PLoS One</source>
<year>2013</year>
<volume>8</volume>
<elocation-id>e68599</elocation-id>
</element-citation></ref>
<ref id="b60-kjim-2019-097">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wada</surname><given-names>K</given-names></name>
<name><surname>Yatsuya</surname><given-names>H</given-names></name>
<name><surname>Ouyang</surname><given-names>P</given-names></name>
<etal/>
</person-group>
<article-title>Self-reported medical history was generally accurate among Japanese workplace population</article-title>
<source>J Clin Epidemiol</source>
<year>2009</year>
<volume>62</volume>
<fpage>306</fpage>
<lpage>313</lpage>
</element-citation></ref>
</ref-list>
<sec sec-type="display-objects">
<title>Tables</title>
<table-wrap id="t1-kjim-2019-097" position="float">
<label>Table 1.</label>
<caption><p>General characteristics of the study population according to Fried frailty phenotype (n = 2,936)</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Characteristic</th>
<th align="center" valign="middle">Robust (n = 1,324)</th>
<th align="center" valign="middle">Pre-frail (n = 1,364)</th>
<th align="center" valign="middle">Frail (n = 248)</th>
<th align="center" valign="middle"><italic>p</italic> value</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Age, yr</td>
<td valign="top" align="center">75.1 &#x000B1; 3.6</td>
<td valign="top" align="center">76.4 &#x000B1; 3.9</td>
<td valign="top" align="center">78.5 &#x000B1; 3.7</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Male sex</td>
<td valign="top" align="center">755 (57.0)</td>
<td valign="top" align="center">533 (40.5)</td>
<td valign="top" align="center">89 (35.9)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Physical activity, MET-min/wk<sup><xref rid="tfn1-kjim-2019-097" ref-type="table-fn">a</xref></sup></td>
<td valign="top" align="center">59.3 &#x000B1; 61.9</td>
<td valign="top" align="center">51.7 &#x000B1; 65.4</td>
<td valign="top" align="center">21.5 &#x000B1; 38.3</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Body mass index, kg/m<sup>2</sup></td>
<td valign="top" align="center">24.5 &#x000B1; 2.8</td>
<td valign="top" align="center">24.5 &#x000B1; 3.2</td>
<td valign="top" align="center">24.1 &#x000B1; 3.7</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Alcohol drinker</td>
<td valign="top" align="center">290 (21.9)</td>
<td valign="top" align="center">206 (15.1)</td>
<td valign="top" align="center">39 (15.7)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Smoker</td>
<td valign="top" align="center">591 (44.6)</td>
<td valign="top" align="center">455 (33.4)</td>
<td valign="top" align="center">79 (31.9)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Education &gt; 6 yr</td>
<td valign="top" align="center">1,181 (89.2)</td>
<td valign="top" align="center">1,013 (74.3)</td>
<td valign="top" align="center">128 (51.6)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Living with a spouse</td>
<td valign="top" align="center">984 (74.3)</td>
<td valign="top" align="center">855 (62.7)</td>
<td valign="top" align="center">134 (54.0)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Comorbidity, number</td>
<td valign="top" align="center">2.2 &#x000B1; 1.7</td>
<td valign="top" align="center">2.4 &#x000B1; 1.7</td>
<td valign="top" align="center">2.7 &#x000B1; 1.4</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Polypharmacy</td>
<td valign="top" align="center">220 (16.6)</td>
<td valign="top" align="center">361 (26.5)</td>
<td valign="top" align="center">107 (43.1)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>Values are presented as mean &#x000B1; SD or number (%). Polypharmacy was defined as the ingestion of five or more prescribed medications.</p></fn>
<fn id="tfn1-kjim-2019-097"><label>a</label><p>Met-min/wk, activity amount by metabolic equivalents of task &#x000D7; minutes per week.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t2-kjim-2019-097" position="float">
<label>Table 2.</label>
<caption><p>Associations between current illnesses and frailty status</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle">Variable</th>
<th align="center" valign="middle">Robust (n = 1,324)</th>
<th align="center" valign="middle">Pre-frail (n = 1,364)</th>
<th align="center" valign="middle">Frail (n = 248)</th>
<th align="center" valign="middle"><italic>p</italic> value</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Hypertension</td>
<td valign="top" align="center">713 (53.9)</td>
<td valign="top" align="center">829 (60.8)</td>
<td valign="top" align="center">160 (64.5)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus</td>
<td valign="top" align="center">244 (18.4)</td>
<td valign="top" align="center">333 (24.4)</td>
<td valign="top" align="center">74 (29.8)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Myocardial infarction</td>
<td valign="top" align="center">27 (2.0)</td>
<td valign="top" align="center">31 (2.3)</td>
<td valign="top" align="center">8 (3.2)</td>
<td valign="top" align="center">0.510</td>
</tr>
<tr>
<td valign="top" align="left">Congestive heart failure</td>
<td valign="top" align="center">6 (0.5)</td>
<td valign="top" align="center">10 (0.7)</td>
<td valign="top" align="center">4 (1.6)</td>
<td valign="top" align="center">0.119</td>
</tr>
<tr>
<td valign="top" align="left">Angina</td>
<td valign="top" align="center">75 (5.7)</td>
<td valign="top" align="center">86 (6.3)</td>
<td valign="top" align="center">21 (8.5)</td>
<td valign="top" align="center">0.238</td>
</tr>
<tr>
<td valign="top" align="left">Asthma</td>
<td valign="top" align="center">37 (2.8)</td>
<td valign="top" align="center">48 (3.5)</td>
<td valign="top" align="center">15 (6.0)</td>
<td valign="top" align="center">0.033</td>
</tr>
<tr>
<td valign="top" align="left">COPD</td>
<td valign="top" align="center">14 (1.1)</td>
<td valign="top" align="center">14 (1.0)</td>
<td valign="top" align="center">3 (1.2)</td>
<td valign="top" align="center">0.967</td>
</tr>
<tr>
<td valign="top" align="left">Chronic bronchitis</td>
<td valign="top" align="center">15 (1.1)</td>
<td valign="top" align="center">23 (1.7)</td>
<td valign="top" align="center">7 (2.8)</td>
<td valign="top" align="center">0.114</td>
</tr>
<tr>
<td valign="top" align="left">Emphysema</td>
<td valign="top" align="center">5 (0.4)</td>
<td valign="top" align="center">2 (0.1)</td>
<td valign="top" align="center">0</td>
<td valign="top" align="center">0.340</td>
</tr>
<tr>
<td valign="top" align="left">Arthritis</td>
<td valign="top" align="center">248 (18.7)</td>
<td valign="top" align="center">446 (32.7)</td>
<td valign="top" align="center">93 (37.5)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;Osteoarthritis</td>
<td valign="top" align="center">241 (18.2)</td>
<td valign="top" align="center">414 (30.4)</td>
<td valign="top" align="center">88 (35.5)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">&#x02003;Rheumatoid arthritis</td>
<td valign="top" align="center">11 (0.8)</td>
<td valign="top" align="center">43 (3.2)</td>
<td valign="top" align="center">6 (2.4)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Osteoporosis</td>
<td valign="top" align="center">147 (11.1)</td>
<td valign="top" align="center">275 (20.2)</td>
<td valign="top" align="center">54 (21.8)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Stroke</td>
<td valign="top" align="center">51 (3.9)</td>
<td valign="top" align="center">78 (5.7)</td>
<td valign="top" align="center">14 (5.6)</td>
<td valign="top" align="center">0.067</td>
</tr>
<tr>
<td valign="top" align="left">Depression</td>
<td valign="top" align="center">35 (2.6)</td>
<td valign="top" align="center">35 (2.6)</td>
<td valign="top" align="center">6 (2.4)</td>
<td valign="top" align="center">0.977</td>
</tr>
<tr>
<td valign="top" align="left">Urinary incontinence</td>
<td valign="top" align="center">29 (2.2)</td>
<td valign="top" align="center">60 (4.4)</td>
<td valign="top" align="center">24 (9.7)</td>
<td valign="top" align="center">&lt; 0.001</td>
</tr>
<tr>
<td valign="top" align="left">Kidney disease<sup><xref rid="tfn2-kjim-2019-097" ref-type="table-fn">a</xref></sup></td>
<td valign="top" align="center">14 (1.1)</td>
<td valign="top" align="center">25 (1.8)</td>
<td valign="top" align="center">7 (2.8)</td>
<td valign="top" align="center">0.068</td>
</tr>
<tr>
<td valign="top" align="left">Liver disease<sup><xref rid="tfn3-kjim-2019-097" ref-type="table-fn">b</xref></sup></td>
<td valign="top" align="center">17 (1.3)</td>
<td valign="top" align="center">22 (1.6)</td>
<td valign="top" align="center">2 (0.8)</td>
<td valign="top" align="center">0.658</td>
</tr>
<tr>
<td valign="top" align="left">Heart disease<sup><xref rid="tfn4-kjim-2019-097" ref-type="table-fn">c</xref></sup></td>
<td valign="top" align="center">104 (7.9)</td>
<td valign="top" align="center">124 (9.1)</td>
<td valign="top" align="center">29 (11.7)</td>
<td valign="top" align="center">0.121</td>
</tr>
<tr>
<td valign="top" align="left">Lung disease<sup><xref rid="tfn5-kjim-2019-097" ref-type="table-fn">d</xref></sup></td>
<td valign="top" align="center">67 (5.1)</td>
<td valign="top" align="center">81 (5.9)</td>
<td valign="top" align="center">24 (9.7)</td>
<td valign="top" align="center">0.017</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>Values are presented as number (%).</p></fn>
<fn id="tfn2-kjim-2019-097"><label>a</label><p>Kidney disease: includes chronic kidney disease, chronic renal failure, (excluding urinary stones).</p></fn>
<fn id="tfn3-kjim-2019-097"><label>b</label><p>Liver disease: includes moderate or severe liver disease (concomitant esophageal varix, hepatic failure, toxic hepatitis, portal hypertension, and hepatorenal syndrome).</p></fn>
<fn id="tfn4-kjim-2019-097"><label>c</label><p>Heart disease: includes myocardial infarction, angina, and congestive heart failure.</p></fn>
<fn id="tfn5-kjim-2019-097"><label>d</label><p>Lung disease: includes asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema.</p></fn>
</table-wrap-foot>
</table-wrap>

<table-wrap id="t3-kjim-2019-097" position="float">
<label>Table 3.</label>
<caption><p>Logistic regression for frailty according to illnesses</p></caption>
<table rules="groups" frame="hsides">
<thead><tr>
<th align="left" valign="middle" rowspan="2">Illnesses</th>
<th align="center" valign="middle" colspan="2">Model 1<sup><xref rid="tfn6-kjim-2019-097" ref-type="table-fn">a</xref></sup><hr/></th>
<th align="center" valign="middle" colspan="2">Model 2<sup><xref rid="tfn7-kjim-2019-097" ref-type="table-fn">b</xref></sup><hr/></th>
<th align="center" valign="middle" colspan="2">Model 3<sup><xref rid="tfn8-kjim-2019-097" ref-type="table-fn">c</xref></sup><hr/></th>
</tr><tr>
<th align="center" valign="middle">OR (95% CI)</th>
<th align="center" valign="middle"><italic>p</italic> value</th>
<th align="center" valign="middle">OR (95% CI)</th>
<th align="center" valign="middle"><italic>p</italic> value</th>
<th align="center" valign="middle">OR (95% CI)</th>
<th align="center" valign="middle"><italic>p</italic> value</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Hypertension</td>
<td valign="top" align="center">1.35 (1.03&#x02013;1.77)</td>
<td valign="top" align="center">0.030</td>
<td valign="top" align="center">1.11 (0.84&#x02013;1.47)</td>
<td valign="top" align="center">0.472</td>
<td valign="top" align="center">1.03 (0.77&#x02013;1.38)</td>
<td valign="top" align="center">0.829</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus</td>
<td valign="top" align="center">1.56 (1.17&#x02013;2.07)</td>
<td valign="top" align="center">0.003</td>
<td valign="top" align="center">1.53 (1.14&#x02013;2.06)</td>
<td valign="top" align="center">0.005</td>
<td valign="top" align="center">1.51 (1.10&#x02013;2.01)</td>
<td valign="top" align="center">0.010</td>
</tr>
<tr>
<td valign="top" align="left">Arthritis</td>
<td valign="top" align="center">1.72 (1.31&#x02013;2.26)</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">1.36 (1.02&#x02013;1.82)</td>
<td valign="top" align="center">0.037</td>
<td valign="top" align="center">1.26 (0.98&#x02013;1.72)</td>
<td valign="top" align="center">0.139</td>
</tr>
<tr>
<td valign="top" align="left">Stroke</td>
<td valign="top" align="center">1.19 (0.67&#x02013;2.09)</td>
<td valign="top" align="center">0.554</td>
<td valign="top" align="center">1.45 (0.80&#x02013;2.60)</td>
<td valign="top" align="center">0.218</td>
<td valign="top" align="center">1.3 (0.70&#x02013;2.43)</td>
<td valign="top" align="center">0.404</td>
</tr>
<tr>
<td valign="top" align="left">Kidney disease</td>
<td valign="top" align="center">1.97 (0.87&#x02013;4.46)</td>
<td valign="top" align="center">0.102</td>
<td valign="top" align="center">1.82 (0.78&#x02013;4.27)</td>
<td valign="top" align="center">0.167</td>
<td valign="top" align="center">2.01 (0.85&#x02013;5.15)</td>
<td valign="top" align="center">0.110</td>
</tr>
<tr>
<td valign="top" align="left">Heart disease</td>
<td valign="top" align="center">1.43 (0.95&#x02013;2.15)</td>
<td valign="top" align="center">0.088</td>
<td valign="top" align="center">1.39 (0.91&#x02013;2.13)</td>
<td valign="top" align="center">0.131</td>
<td valign="top" align="center">1.33 (0.85&#x02013;1.07)</td>
<td valign="top" align="center">0.215</td>
</tr>
<tr>
<td valign="top" align="left">Lung disease</td>
<td valign="top" align="center">1.84 (1.17&#x02013;2.89)</td>
<td valign="top" align="center">0.008</td>
<td valign="top" align="center">1.53 (0.96&#x02013;2.45)</td>
<td valign="top" align="center">0.077</td>
<td valign="top" align="center">1.58 (0.96&#x02013;2.01)</td>
<td valign="top" align="center">0.072</td>
</tr>
<tr>
<td valign="top" align="left">Urinary incontinence</td>
<td valign="top" align="center">3.13 (1.95&#x02013;5.01)</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">2.44 (1.48&#x02013;4.02)</td>
<td valign="top" align="center">&lt; 0.001</td>
<td valign="top" align="center">1.88 (1.11&#x02013;3.18)</td>
<td valign="top" align="center">0.020</td>
</tr>
<tr>
<td valign="top" align="left">Osteoporosis</td>
<td valign="top" align="center">1.50 (1.09&#x02013;2.06)</td>
<td valign="top" align="center">0.014</td>
<td valign="top" align="center">1.13 (0.80&#x02013;1.60)</td>
<td valign="top" align="center">0.486</td>
<td valign="top" align="center">1.04 (0.72&#x02013;0.48)</td>
<td valign="top" align="center">0.854</td>
</tr>
</tbody></table>
<table-wrap-foot>
<fn><p>OR, odds ratio; CI, confidence interval.</p></fn>
<fn id="tfn6-kjim-2019-097"><label>a</label><p>Model 1: not adjusted.</p></fn>
<fn id="tfn7-kjim-2019-097"><label>b</label><p>Model 2: adjusted for age, sex.</p></fn>
<fn id="tfn8-kjim-2019-097"><label>c</label><p>Model 3: adjusted for age, sex, physical activities, smoking, alcohol, education, spouse.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</back></article>